Drug interaction represents a major problem in day-to-day practice. The incidence of adverse reactions increases almost exponentially as the number of drugs co prescribed rises, and this is in part due to interaction. Critically ill, chronically ill and elderly patients are particularly at risk of drug interactions due to polypharmacy as well as impaired homeostatic mechanisms. The study was aimed to assess polypharmacy and drug interaction in the prescriptions. The study was carried out by taking 200 prescriptions from different departments of our hospital and assessed the drug interaction through Micromedex and Drugs update. Polypharmacy was assessed using Prescribing indicators in WHO drug use indicators. Polypharmacy was observed in 85% of the prescriptions and drug interaction was observed in 58.5% of the prescriptions.
INTRODUCTION:
Drug interactions and side effects are the negative but real consequences of pharmacological therapy. The more medications patients take, the greater the potential for drug-drug interactions.
Critically ill, chronically ill and elderly patients are particularly at risk of drug interactions due to polypharmacy as well as impaired homeostatic mechanisms.
Polypharmacy" carries negative connotations, including increased costs, poorer compliance, and increased risk of side effects and drug interactions.
Objective:
The objectives were to study the incidence and pattern of Drug interaction in our hospital and to identify whether it is associated with Polypharmacy.
MATERIAL AND METHODS:
It is a Prospective Observational study using 200 out patient and in patient prescriptions from different departments in a tertiary care hospital.
Prescriptions from Surgical ward as well as OBG ward were excluded as the number of drugs prescribed will be increased in case of surgical prophylaxis.
RESULT AND DISCUSSION:
Polypharmacy and assosciated ADRs are well established in older patients since they are more likely to be affected by multiple chronic conditions and multiple uses of drugs. In developing countries like India, there are no stringent regulations about the use of drugs.
 A total of 117 prescriptions (58.5%) were found to have drug interactions in 200 prescriptions. Out of which 78(66.6%) were male and 39(33.3%) were female patients (graph 1). It shows that the prevalence of polypharmacy in female is 2-fold compared to male.
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GRAPH 1
 Out of 117 drug interactions, 85 (72.6%) were reported from Out Patient department and remaining 32 (27.3%) were from In patient department (graph2).
 Age was found to be an important criteria in the fact that the patients in the age group 51-70 years has experienced maximum DIs (61.5%) followed by 23% in the age group 41-50 years-table 1. 
